B-cell lymphomas involving Waldeyer's ring characterized by distinctive clinical and histopathological features: a comparison of pediatric to adult patients

被引:9
作者
Chen, Lei [1 ]
Al-Kzayer, Lika'a Fasih Y. [2 ]
Liu, Yi [1 ]
Liu, Tingting [3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pathol, Shanghai, Peoples R China
[2] Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan
[3] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Hematol Oncol, Shanghai, Peoples R China
关键词
B-cell lymphoma; Waldeyer's ring; MUM1 positive lymphoma; HIGH PROLIFERATION INDEX; NON-HODGKIN-LYMPHOMA; FOLLICULAR-LYMPHOMA; PROGNOSTIC-SIGNIFICANCE; YOUNG-ADULTS; EXPRESSION; CHILDREN; SUBTYPE; CLASSIFICATION; COEXPRESSION;
D O I
10.18632/oncotarget.14581
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-cell lymphomas involving Waldeyer's ring (WR) comprise heterogeneous histolopathological subtypes with a wide age range and distinctive clinical features. However, the comparison between pediatric and adult patients is scarce and limited in the literature. Thirty-three cases of B-cell lymphomas involving WR, were collected and evaluated by histolopathological, immunohistochemical and FISH analyses. The 33 cases were categorized into children and adolescents referred as pediatric group (n = 12), aged (3-19) years and the adult group (n = 21), aged (20-84) years. The pediatric group included Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) and MUM1-positive-lymphoma in 7, 3 and 2 cases, respectively. While the adult cases comprised of DLBCL, follicular lymphoma, and mucosa associated lymphoid tissue (MALT) lymphoma in 18, 2 and 1 case, respectively. Male gender was predominant in both groups with 3 folds frequency in the pediatric cases compared to 2 folds in the adults counterpart. Pediatric cases showed a significantly higher frequency of stage I disease (P = 0.019), germinal and MYC breaks (P = 0.029) compared to adults. However, MUM1 positive expression was less frequently detected in pediatric patients than adults (P = 0.082). BCL2 rearrangement was undetectable in both pediatric and adult groups. On the other hand, adult group had the significantly higher proportion of DLBCL (P < 0.001), BCL2 expression (P = 0.027) and stage II disease (P = 0.047) compared to pediatric group. In conclusion, B-cell lymphomas involving WR presented with a wide age range, and evident variation in clinical features, histopathological subtypes and immunophenotypes between pediatric and adult age groups.
引用
收藏
页码:11544 / 11554
页数:11
相关论文
共 21 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis [J].
Berglund, M ;
Thunberg, U ;
Amini, RM ;
Book, M ;
Roos, G ;
Erlanson, M ;
Linderoth, J ;
Dictor, M ;
Jerkeman, M ;
Cavallin-Ståhl, E ;
Sundström, C ;
Rehn-Eriksson, S ;
Backlin, C ;
Hagberg, H ;
Rosenquist, R ;
Enblad, G .
MODERN PATHOLOGY, 2005, 18 (08) :1113-1120
[3]   Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma [J].
Broyde, Adi ;
Boycov, Olga ;
Strenov, Yulia ;
Okon, Elimelech ;
Shpilberg, Ofer ;
Bairey, Osnat .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (06) :338-343
[4]   IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10 [J].
Chen, Lei ;
Al-Kzayer, Lika'a Fasih Y. ;
Liu, Tingting ;
Kobayashi, Norimoto ;
Nakazawa, Yozo ;
Koike, Kenichi .
PEDIATRIC BLOOD & CANCER, 2017, 64 (02) :311-314
[5]   Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study [J].
de Leval, L. ;
Bonnet, C. ;
Copie-Bergman, C. ;
Seidel, L. ;
Baia, M. ;
Briere, J. ;
Molina, T. J. ;
Fabiani, B. ;
Petrella, T. ;
Bosq, J. ;
Gisselbrecht, C. ;
Siebert, R. ;
Tilly, H. ;
Haioun, C. ;
Fillet, G. ;
Gaulard, P. .
ANNALS OF ONCOLOGY, 2012, 23 (12) :3143-3151
[6]   Clinical manifestations in children with tonsillar lymphoma: A systematic review [J].
Guimaraes, Alexandre Caixeta ;
de Carvalho, Guilherme Machado ;
Bento, Lucas Ricci ;
Correa, Carlos ;
Gusmao, Reinaldo Jordao .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 90 (02) :146-151
[7]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282
[8]   MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program [J].
Hu, Shimin ;
Xu-Monette, Zijun Y. ;
Tzankov, Alexander ;
Green, Tina ;
Wu, Lin ;
Balasubramanyam, Aarthi ;
Liu, Wei-min ;
Visco, Carlo ;
Li, Yong ;
Miranda, Roberto N. ;
Montes-Moreno, Santiago ;
Dybkaer, Karen ;
Chiu, April ;
Orazi, Attilio ;
Zu, Youli ;
Bhagat, Govind ;
Richards, Kristy L. ;
Hsi, Eric D. ;
Choi, William W. L. ;
Zhao, Xiaoying ;
van Krieken, J. Han ;
Huang, Qin ;
Huh, Jooryung ;
Ai, Weiyun ;
Ponzoni, Maurilio ;
Ferreri, Andres J. M. ;
Zhou, Fan ;
Slack, Graham W. ;
Gascoyne, Randy D. ;
Tu, Meifeng ;
Variakojis, Daina ;
Chen, Weina ;
Go, Ronald S. ;
Piris, Miguel A. ;
Moller, Michael B. ;
Medeiros, L. Jeffrey ;
Young, Ken H. .
BLOOD, 2013, 121 (20) :4021-4031
[9]   BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma [J].
Iqbal, J ;
Neppalli, VT ;
Wright, G ;
Dave, LJ ;
Horsman, DE ;
Rosenwald, A ;
Lynch, J ;
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Campo, E ;
Ott, G ;
Müller-Hermelink, HK ;
Delabie, J ;
Jaffe, ES ;
Grogan, TM ;
Connors, JM ;
Vose, JM ;
Armitage, JO ;
Staudt, LM ;
Chan, WC .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :961-968
[10]   Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [J].
Johnson, Nathalie A. ;
Slack, Graham W. ;
Savage, Kerry J. ;
Connors, Joseph M. ;
Ben-Neriah, Susana ;
Rogic, Sanja ;
Scott, David W. ;
Tan, King L. ;
Steidl, Christian ;
Sehn, Laurie H. ;
Chan, Wing C. ;
Iqbal, Javeed ;
Meyer, Paul N. ;
Lenz, Georg ;
Wright, George ;
Rimsza, Lisa M. ;
Valentino, Carlo ;
Brunhoeber, Patrick ;
Grogan, Thomas M. ;
Braziel, Rita M. ;
Cook, James R. ;
Tubbs, Raymond R. ;
Weisenburger, Dennis D. ;
Campo, Elias ;
Rosenwald, Andreas ;
Ott, German ;
Delabie, Jan ;
Holcroft, Christina ;
Jaffe, Elaine S. ;
Staudt, Louis M. ;
Gascoyne, Randy D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) :3452-3459